OMCL

Omnicell Inc

OMCL, USA

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.

https://www.omnicell.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OMCL
stock
OMCL

Taking Stock of Omnicell (OMCL) After Titan XT Launch: What the New Platform Means for Valuation simplywall.st

Read more →
OMCL
stock
OMCL

Omnicell, Inc. $OMCL Stock Holdings Raised by Liontrust Investment Partners LLP MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$47.3333

Analyst Picks

Strong Buy

3

Buy

1

Hold

4

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

84.00

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Low

1.68

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

0.45 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.28 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

5.96 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Medium

0.60

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 107.33% of the total shares of Omnicell Inc

1.

BlackRock Inc

(17.054%)

since

2025/06/30

2.

Vanguard Group Inc

(12.2709%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(6.0646%)

since

2025/08/31

4.

Dimensional Fund Advisors, Inc.

(4.7168%)

since

2025/06/30

5.

State Street Corp

(4.5554%)

since

2025/06/30

6.

Lazard Asset Management LLC

(3.7191%)

since

2025/06/30

7.

Cadian Capital Management LP

(3.6205%)

since

2025/06/30

8.

Sumitomo Mitsui Trust Group Inc

(3.0992%)

since

2025/06/30

9.

Lazard Global Robotics & Automation

(3.0992%)

since

2025/06/30

10.

D. E. Shaw & Co LP

(3.095%)

since

2025/06/30

11.

Victory Capital Management Inc.

(2.98%)

since

2025/06/30

12.

Macquarie Group Ltd

(2.9605%)

since

2025/06/30

13.

Vanguard Total Stock Mkt Idx Inv

(2.9354%)

since

2025/07/31

14.

Geode Capital Management, LLC

(2.6035%)

since

2025/06/30

15.

iShares Russell 2000 ETF

(2.4433%)

since

2025/08/31

16.

Vanguard Small Cap Index

(2.3506%)

since

2025/07/31

17.

Macquarie Small Cap Core I

(2.2404%)

since

2025/07/31

18.

Victory Sycamore Small Company Opp R

(2.0355%)

since

2025/06/30

19.

Citadel Advisors Llc

(1.9554%)

since

2025/06/30

20.

Wellington Management Company LLP

(1.7507%)

since

2025/06/30

21.

Morgan Stanley - Brokerage Accounts

(1.5481%)

since

2025/06/30

22.

Vanguard Small Cap Value Index Inv

(1.5176%)

since

2025/07/31

23.

Royal Bank of Canada

(1.5133%)

since

2025/06/30

24.

Qube Research & Technologies

(1.4237%)

since

2025/06/30

25.

Charles Schwab Investment Management Inc

(1.3411%)

since

2025/06/30

26.

Federated Hermes Inc

(1.2952%)

since

2025/06/30

27.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

(1.2838%)

since

2025/06/30

28.

Global X Robotics & Artfcl Intllgnc ETF

(1.1525%)

since

2025/08/29

29.

DFA US Small Cap Value I

(1.1289%)

since

2025/07/31

30.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0974%)

since

2025/07/31

31.

Northern Trust Corp

(1.083%)

since

2025/06/30

32.

Fidelity Small Cap Index

(1.0185%)

since

2025/06/30

33.

iShares S&P Small-Cap 600 Value ETF

(0.9487%)

since

2025/08/31

35.

iShares Russell 2000 Value ETF

(0.8964%)

since

2025/08/31

36.

BlackRock Global Equity Mkt Netrl Instl

(0.77%)

since

2025/07/31

37.

Federated Hermes MDT Small Cap Core IS

(0.7406%)

since

2025/06/30

38.

Federated Hermes MDT SCC Institutional

(0.7406%)

since

2025/06/30

39.

Vanguard Strategic Equity Inv

(0.7094%)

since

2025/06/30

40.

Vanguard Tax-Managed Small Cap Adm

(0.661%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.51

EPS Estimate

0.36

EPS Difference

0.15

Surprise Percent

41.6667%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(4)
Growth
Moderate Growth(3.5)
Momentum
Strong Momentum(6.5)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(5.5)
Value
Undervalued(6.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.